← Scroll for more →
Recent Updates — UEEC
July 10, 2026View Source ↗
United Health Products, Inc. announced an agreement with NAMSA, a global MedTech contract research organization, to serve as the regulatory sponsor for a new clinical study of CelluSTAT Hemostatic Gauze. This study is intended to support the company's FDA Premarket Approval (PMA) application. United Health Products, Inc. operates in the medical device industry and develops hemostatic products for wound care.